Women's issues in mood disorders (Q34182002)

31 July 2017

1 reference

title

Women's issues in mood disorders (English)

1 reference

31 July 2017

Goodnick PJ

1

1 reference

31 July 2017

Chaudry T

series ordinal

2

1 reference

31 July 2017

Artadi J

series ordinal

3

1 reference

31 July 2017

Arcey S

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

1

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

903-916

1 reference

Forms of atypical depression and their response to antidepressant drugs

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Breast enlargement during chronic antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Sertraline treatment does not increase plasma prolactin levels in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Desipramine clearance in children and adolescents: absence of effect of development and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

The role of fluoxetine in the treatment of premenstrual dysphoric disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Paroxetine as a treatment for premenstrual dysphoric disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Neurodevelopment of children exposed in utero to antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Serum nortriptyline levels in nursing mothers and their infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Possible association between fluoxetine hydrochloride and colic in an infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Citalopram and breast-feeding: serum concentration and side effects in the infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Mood disorders and menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

A reevaluation of risk of in utero exposure to lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

What happened later to the lithium babies? A follow-up study of children born without malformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Prenatal diagnosis of spina bifida aperta after first‐trimester valproate exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

Epidemiology of puerperal psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.903

21 January 2018

Identifiers

DOI

10.1517/14656566.1.5.903

1 reference

31 July 2017

1 reference